期刊文献+

心肌肌钙蛋白T和CK在老年重症肺炎患者中的临床意义及对预后的影响 被引量:2

Clinical significance of serum cardiac troponin T and creatine kinase levies in elderly patients with severe pneumonia
下载PDF
导出
摘要 目的探讨血清心肌肌钙蛋白T(cTnT)和CK在老年重症肺炎患者中的临床意义及对预后的影响。方法观察181例老年重症肺炎患者入院后3d内最高cTnT、CK测值和APACHEII评分,并对3者进行相关性分析。将患者分为cTnT正常组和升高组,比较两组的APACHEII评分和病死率。依据预后分为生存组和死亡组,比较两组cTnT、CK测值的变化。结果cTnT正常组APACHEII评分和死亡例数与升高组差异有统计学意义(P〈005)。生存组cTnT、CK测值和APACHEII评分与死亡组差异均有统计学意义(均P〈0.01),cTnT、CK与APACHEII评分3者之间呈正相关(均P〈0.01)。生存组cTnT、CK和APACHEII评分为(0.056±0.023)ng/ml、(13567±2071)μg/L和(17.4±2.8)分;死亡组cTnT、CK和APACHEII评分为(0.92±0.035)ng/ml、(210.22±32.6)μg/L和(24.8±5.6)分。结论老年重症患者cTnT、CK升高较常见,cTnT、CK监测对判断老年重症肺炎的预后具有一定临床意义。 Objective To investigate the clinical significance of serum cardiac tropinin T (cTnT) and creatine kinase (CK) levels in elderly patients with sever pneumonia. Methods Serum cTnT and CK levels were measured and APACHE II scores were assessed in 181 elderly patients with severe pneumonia within 3d after adimission. Patients were stratified into elevated and normal cTnT groups accordig to serum cTnT levels. Results There were significant differences in APACHE II score and mortality between the elevated and normal cTnT groups (P〈0.05). Serum cTnT levels were positively correlated with CK levels and APACHE II scores (P〈0.01). Serum cTnT, CK and APACHE II score in the survival group were 0.056±0.023 ng/ml, 135.67 ± 20.71 p g/L and 17.4 ±2.8 respectively, while those in the fatal group were 0.92 ± 0.035ng/ml, 210.22 ± 32.6 μg/L and 24.8 ±5.6 respectively. Conclusion Serum cTnT and CK levels can be used for evaluation of the prognosis in elderly patients with severe pneumonia.
出处 《浙江医学》 CAS 2012年第20期1665-1666,1699,共3页 Zhejiang Medical Journal
关键词 肌钙蛋白T 肌酸磷酸激酶 重症肺炎 老年患者 预后 Tropinin T Creatine kinase Severe pneumonia Elder patients Prognosis
  • 相关文献

参考文献7

二级参考文献22

  • 1李毅,于学忠,王仲,马遂.肌钙蛋白Ⅰ测定在感染性休克监测中的作用[J].中国急救医学,2005,25(9):633-635. 被引量:14
  • 2宋花玲,贺佳,黄品贤,李素云.ROC曲线下面积估计的参数法与非参数法的应用研究[J].第二军医大学学报,2006,27(7):726-728. 被引量:75
  • 3Baudouin SV.The pulmonary physician in critical care 3: critical care management of community acquired pneumonia.Thorax,2002,57:267-271.
  • 4American Thoracic Society.Guidelines for the management of adults with community acquired pneumonia.Am J Respir Crit Care Med,2001,163:1730-1754.
  • 5Fine MJ,Auble TE,Yearly DM,et al.A prediction rule to identify low-risk patients with commu-nity-acquired pneumonia.N Engl J Med,1997,336:243-250.
  • 6Feldman C.Pneumonia in the elderly.Med Clin North Am,2001,85: 1441-1459.
  • 7Marrie TJ.Community-acquired pneumonia in the elderly.Clin Infect Dis,2000,31:1066-1078.
  • 8Fedsion DS,Baldwin JA.Previous hospital care as a risk factor for pneumonia: implications for immunization with pneumococcal vaccine.JAMA,1982,248:1989-1995.
  • 9Woodhead MA,MacFarlane JT,McCracken JS,et al.Prospective study of aetiology and outcome of pneumonia in the community.Lancet: 1987,1: 671-674.
  • 10Woodhead M.Community-acquired pneumonia guidelines: an international comparison.Chest,1998,113: 183-187S.

共引文献127

同被引文献19

引证文献2

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部